Oxis International Overview
- Year Founded
-
1966
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
9
- Investments
-
2
Oxis International General Information
Description
GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its key drug candidates are OXS-2175, targeting the treatment of triple-negative breast cancer; OXS-4235, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, targets cancer cells expressing the CD19 receptor and CD22 receptor.
Contact Information
Corporate Office
- 100 South Ashley Drive
- Suite 600
- Tampa, FL 33609
- United States
Corporate Office
- 100 South Ashley Drive
- Suite 600
- Tampa, FL 33609
- United States
Oxis International Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Oxis International Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Oxis International Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Oxis International Acquisitions (2)
Oxis International’s most recent deal was a Reverse Merger with GT Biopharma. The deal was made on 05-Sep-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| GT Biopharma | 05-Sep-2017 | Reverse Merger | Drug Discovery | ||
| BioCheck | 08-Dec-2005 | Merger/Acquisition | Diagnostic Equipment |
Oxis International Exits (1)
Oxis International’s most recent exit was on 08-Dec-2005 from BioCheck. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| BioCheck | 08-Dec-2005 | Completed |
|
Oxis International FAQs
-
When was Oxis International founded?
Oxis International was founded in 1966.
-
Where is Oxis International headquartered?
Oxis International is headquartered in Tampa, FL.
-
What industry is Oxis International in?
Oxis International’s primary industry is Pharmaceuticals.
-
Is Oxis International a private or public company?
Oxis International is a Private company.
-
What is Oxis International’s current revenue?
The current revenue for Oxis International is .
-
How much funding has Oxis International raised over time?
Oxis International has raised $12.9M.
-
Who are Oxis International’s investors?
American Healthcare Systems, Axonyx, Bristol Investment Group, Reference Capital Management, and SR One are 5 of 7 investors who have invested in Oxis International.
-
When was Oxis International acquired?
Oxis International was acquired on 05-Sep-2017.
-
Who acquired Oxis International?
Oxis International was acquired by GT Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
